We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Emmit | LSE:EMT | London | Ordinary Share | GB00BFN09H12 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 97.50 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
7 November 2014 Emmit Plc ("Emmit" or the "Company") Update on Investing Policy and Potential Acquisition Talks Further to the announcement on 5 November, the Company announces an update on its investing policy and the two investments made earlier this year. On 14 November 2013, the Company's shareholders voted to adopt an investing policy focusing on investments in the environment, leisure and technology sectors, using the Company's equity as consideration. On 11 March 2014, Emmit announced that it had acquired a 20 per cent. holding in Ximax Environmental Solutions Plc ("XES"), a niche water treatment company, for £30,000, satisfied through the issue of 500,000 new Emmit shares and the issue of 4,500,000 warrants at 6p per share. Then, on 25 March 2014, Emmit announced that it had acquired 25 per cent. of Ximax Oil & Gas Solutions ("XOG"), a company which has developed water treatment applications aimed at the Oil and Gas industry, which is an associate company to XES, for £90,000, satisfied through the issue of 1,800,000 warrants at 6p per share. Information on XES and XOG The following information on the performances of both businesses was previously provided to investors in announcements on 26 August 2014 and 30 September 2014. Further information can also be found on www.ximaxes.com. Formed in 2009, XES has developed a proprietary high purity chlorine dioxide solution, XzioX, an environmentally friendly and trade-marked, cost effective biocide and disinfection product. XzioX is currently used by 200 agricultural clients in the UK and Ireland, of which 50 have been secured in XES's current financial year. Overseas, XES secured an order for £100,000 from a Dubai governmental body in April of this year and continues to engage in discussions in the United Arab Emirates ("UAE") regarding the supply of XzioX for the treatment of water in parks and fountains throughout the region. Turnover for XES for the year to February 2014 was £2,080,927 (2013: £11,583,414). The drop was due to the inclusion in the previous year of specialist equipment for the oil and gas trials, which were successfully completed earlier this year. Pre-tax profit for the period was £373,667 (2013: £589,484). Turnover for the six months to September 2014 was £814,797, with profit of £397,415. Alongside the growth in XES's domestic operations, which is expected to provide a boost to XES's turnover and profits in the year to February 2015, the Board of Emmit has been particularly encouraged by the positive progress made with potential clients in the UAE. XES has recently completed successful field trials with a major potential customer and, with other smaller customers currently being converted into orders, the Board remains confident in the potential for the opportunities in the UAE to drive a step change in the company's fortunes. XOG was formed in January 2011, to further develop and enhance Xziox for specialist water treatment applications in the Oil and Gas industry, under the registered brand name of FlowXcel. In August 2014, following successful field trials earlier this year, XOG, through its US distributor, American Flo Excel, LLC, signed a 10 year agreement with ROLCO Energy Services (www.rolcoenergyservices.com) to supply Ximax's FlowXcel product for water treatment in the US unconventional oil and gas industry (the "ROLCO contract"). A third order for £100,000 has recently been received, bringing the turnover under the ROLCO contract to £300,000 in the last 6 weeks. With the expectation of regular orders to follow in the future, the Board believes that XOG has strong growth prospects and will be a major driver of value for Emmit. Financial Information on Emmit On 30 September 2014, the Company released its interims results to 30 June 2013. These showed a balance sheet with negative equity of £154,000. However, since the end of the interim period, as announced on 26 August 2014, all the outstanding convertible loan notes have been converted into ordinary equity, 1 million warrants have been exercised and a further £70,000 of new capital has been raised. As well as strengthening the balance sheet, the impact of this has been to clear nearly all of Emmit's financial liabilities and provide the Company with sufficient working capital whilst it looks to either complete its investing policy or carry out a reverse transaction. Potential Acquisition and Suspension under Rule 14 of the AIM Rules The Company is currently in discussions with the shareholders of XES and XOG (together "Ximax") regarding the potential acquisition of the shares in Ximax not currently owned by Emmit. The exact terms of such an acquisition are still being finalised as it may involve a re-organisation of Ximax prior to any purchase by Emmit. These discussions, if successfully concluded, would result in a reverse takeover of Emmit under Rule 14 of the AIM Rules for Companies ("AIM Rules"). Noting the potential reverse takeover referred to above, trading on AIM in the Company's shares is now subject to suspension pursuant to Rule 14 of the AIM Rules. Accordingly, trading on AIM in the Company's shares will now remain suspended until such time as either an admission document has been published in respect of an acquisition of Ximax or, if such does not proceed, the Company fulfils its investing policy. If neither occurs in six months from today then admission of the Company's shares to trading on AIM will be cancelled. The Board recognises that some shareholders may be frustrated by the recent suspension and there no being no restoration of trading prior to the potential acquisition of Ximax. However, the Board believes that the acquisition of Ximax, if successfully concluded, would be in the best interests of the Company and its shareholders as a whole. The recent FCA notice has not been helpful to these conversations and the Board believes that it is in the Company's best interests now to proceed as quickly as possible with the acquisition of Ximax. Further announcements will be made in due course. For further information please contact: Emmit plc Dean Cook 01473 604504 Managing Director Daniel Stewart & Company Plc Antony Legge / Paul Shackleton 020 7776 6550 Nominated Adviser Alexander David Securities Ltd David Scott 020 7448 9820 Broker
www.emmitplc.com
Copyright er 7 PR Newswire
1 Year Emmit Chart |
1 Month Emmit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions